Skip to main content
Charles Simone II, MD, Radiation Oncology, New York, NY, Memorial Sloan Kettering Cancer Center

CharlesBSimoneIIMD

Radiation Oncology New York, NY

Thoracic Cancer

Research Professor and Chief Medical Officer, New York Proton Center Member, Memorial Sloan Kettering Cancer Center

Overview of Dr. Simone

Dr. Charles Simone is a radiation oncologist in New York, NY and is affiliated with Memorial Sloan Kettering Cancer Center. He received his medical degree from Perelman School of Medicine at the University of Pennsylvania and has been in practice 11 years. He is one of 103 doctors at Memorial Sloan Kettering Cancer Center who specialize in Radiation Oncology. He has more than 100 publications and over 500 citings.

Education & Training

  • National Capital Consortium
    National Capital ConsortiumChief Residency, Radiation Oncology, 2010 - 2011
  • National Capital Consortium
    National Capital ConsortiumResidency, Radiation Oncology, 2007 - 2011
  • Perelman School of Medicine at the University of Pennsylvania
    Perelman School of Medicine at the University of PennsylvaniaClass of 2006

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2019 - 2026
  • MD State Medical License
    MD State Medical License 2007 - 2025
  • PA State Medical License
    PA State Medical License 2011 - 2018
  • American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Caring for Patients with Cancer in the Face of Self-Vulnerability During the COVID-19 Pandemic  
    Charles Simone II, MD, JAMA Oncology

Authored Content

  • Caring for Patients with Cancer in the Face of Self-Vulnerability During the COVID-19 PandemicAugust 2020
  • Utilization of Intensity-Modulated Radiation Therapy for Malignant Pleural Mesothelioma in the United StatesMay 2018

Press Mentions

  • Varian and the Cincinnati Children's/University of Cincinnati Medical Center Proton Therapy Center Announce Promising Results from FAST-01, First-in-Human Clinical Trial of Flash Therapy
    Varian and the Cincinnati Children's/University of Cincinnati Medical Center Proton Therapy Center Announce Promising Results from FAST-01, First-in-Human Clinical Trial of Flash TherapyOctober 24th, 2022
  • MARF to Host International Symposium on Malignant Mesothelioma
    MARF to Host International Symposium on Malignant MesotheliomaJuly 20th, 2022
  • Memorial Sloan Kettering Oncologist Named President of Proton Research Group
    Memorial Sloan Kettering Oncologist Named President of Proton Research GroupFebruary 11th, 2021
  • Join now to see all

Professional Memberships

Hospital Affiliations